Pamela K Carmines1. 1. University of Nebraska College of Medicine, Omaha, Nebraska, USA. pcarmines@unmc.edu
Abstract
PURPOSE OF REVIEW: Diabetes mellitus is the primary cause of end-stage renal disease, yet the mechanisms underlying diabetic nephropathy remain ill-defined. The widely accepted opinion holds that events occurring early during the course of diabetes engender the eventual decline in renal function. This review will summarize recent advances (published January 2008 through June 2009) regarding the renal vascular and glomerular functional changes that occur during the early stage of diabetes. RECENT FINDINGS: Reduced C-peptide levels and increased cyclooxygenase-2 activity both seem to promote diabetic hyperfiltration, presumably via effects on afferent arteriolar tone. In addition, exaggerated tonic influences of K+ channels on afferent arteriolar function likely act in concert with impaired Ca2+ influx responses to changes in membrane potential to promote vasodilation. Mechanisms underlying these changes remain largely speculative. Diabetes may also alter autoregulation of renal blood flow and glomerular filtration rate, as well as provoke afferent arteriolar dilation secondary to alterations in proximal tubular reabsorption; however, conflicting evidence continues to flood the literature concerning these events. SUMMARY: New evidence has expanded our appreciation of the complexity of events that promote preglomerular vasodilation during the early stage of diabetes; however, it seems that the more we know, the less we understand.
PURPOSE OF REVIEW: Diabetes mellitus is the primary cause of end-stage renal disease, yet the mechanisms underlying diabetic nephropathy remain ill-defined. The widely accepted opinion holds that events occurring early during the course of diabetes engender the eventual decline in renal function. This review will summarize recent advances (published January 2008 through June 2009) regarding the renal vascular and glomerular functional changes that occur during the early stage of diabetes. RECENT FINDINGS: Reduced C-peptide levels and increased cyclooxygenase-2 activity both seem to promote diabetic hyperfiltration, presumably via effects on afferent arteriolar tone. In addition, exaggerated tonic influences of K+ channels on afferent arteriolar function likely act in concert with impaired Ca2+ influx responses to changes in membrane potential to promote vasodilation. Mechanisms underlying these changes remain largely speculative. Diabetes may also alter autoregulation of renal blood flow and glomerular filtration rate, as well as provoke afferent arteriolar dilation secondary to alterations in proximal tubular reabsorption; however, conflicting evidence continues to flood the literature concerning these events. SUMMARY: New evidence has expanded our appreciation of the complexity of events that promote preglomerular vasodilation during the early stage of diabetes; however, it seems that the more we know, the less we understand.
Authors: Lina Nordquist; En Yin Lai; Mats Sjöquist; Andreas Patzak; A Erik G Persson Journal: Am J Physiol Regul Integr Comp Physiol Date: 2007-12-12 Impact factor: 3.619
Authors: David Z I Cherney; James W Scholey; Rania Nasrallah; Maria G Dekker; Cameron Slorach; Timothy J Bradley; Richard L Hébert; Etienne B Sochett; Judith A Miller Journal: Am J Physiol Renal Physiol Date: 2008-04-09
Authors: Amanda J Edgley; Marianne Tare; Roger G Evans; Con Skordilis; Helena C Parkington Journal: Am J Physiol Regul Integr Comp Physiol Date: 2008-07-16 Impact factor: 3.619
Authors: R Klein; M D Knudtson; B E K Klein; B Zinman; R Gardiner; S Suissa; A R Sinaiko; S M Donnelly; P Goodyer; T Strand; M Mauer Journal: Diabetologia Date: 2010-05-01 Impact factor: 10.122
Authors: Bradley S Miller; Shoshana R Blumenthal; Alexey Shalygin; Kevin D Wright; Alexander Staruschenko; John D Imig; Andrey Sorokin Journal: Diabetes Date: 2018-08-21 Impact factor: 9.461
Authors: T Takenaka; T Inoue; H Okada; Y Ohno; T Miyazaki; D J Chaston; C E Hill; H Suzuki Journal: Diabetologia Date: 2011-05-15 Impact factor: 10.122
Authors: José M Centeno; Luis Miranda-Gómez; Mikahela A López-Morales; Teresa Jover-Mengual; María C Burguete; Vannina G Marrachelli; María Castelló-Ruiz; Alicia Aliena-Valero; Enrique Alborch; Francisco J Miranda Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2018-02-21 Impact factor: 3.000